BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8325704)

  • 1. Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.
    Farace F; Angevin E; Escudier B; Caignard A; Dietrich PY; Genevee C; Hercend T; Triebel F
    Int J Cancer; 1993 Jul; 54(5):741-7. PubMed ID: 8325704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
    Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
    Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy.
    Savelieva E; Farace F; Angevin E; Elias D; Escudier B; Duvillard P; Hercend T; Triebel F
    J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):66-76. PubMed ID: 7521724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.
    Caignard A; Dietrich PY; Morand V; Lim A; Pannetier C; Leridant AM; Hercend T; Even J; Kourilsky P; Triebel F
    Cancer Res; 1994 Mar; 54(5):1292-7. PubMed ID: 8118818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction.
    Genevée C; Diu A; Nierat J; Caignard A; Dietrich PY; Ferradini L; Roman-Roman S; Triebel F; Hercend T
    Eur J Immunol; 1992 May; 22(5):1261-9. PubMed ID: 1533591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.
    Halapi E; Yamamoto Y; Juhlin C; Jeddi-Tehrani M; Grunewald J; Andersson R; Hising C; Masucci G; Mellstedt H; Kiessling R
    Cancer Immunol Immunother; 1993; 36(3):191-7. PubMed ID: 8439980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor V alpha and V beta gene usage by tumour-infiltrating lymphocytes in oral squamous cell carcinoma.
    Mouri T; Nakamura S; Ohyama Y; Matsuzaki G; Shinohara M; Kishihara K; Hiroki A; Oka M; Shirasuna K; Nomoto K
    Cancer Immunol Immunother; 1996 Sep; 43(1):10-8. PubMed ID: 8917630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.
    Farace F; Orlanducci F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
    J Immunol; 1994 Nov; 153(9):4281-90. PubMed ID: 7930628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions.
    Wucherpfennig KW; Newcombe J; Li H; Keddy C; Cuzner ML; Hafler DA
    J Exp Med; 1992 Apr; 175(4):993-1002. PubMed ID: 1348083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patients.
    Angevin E; Farace F; Genevée C; Henry-Amar M; Caignard A; Dietrich PY; Escudier B; Hercend T; Triebel F
    Int J Cancer; 1993 Apr; 54(1):60-7. PubMed ID: 8478148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.
    Wolf B; Schwarzer A; Côté AL; Hampton TH; Schwaab T; Huarte E; Tomlinson CR; Gui J; Fisher JL; Fadul CE; Hamilton JW; Ernstoff MS
    PLoS One; 2012; 7(12):e50221. PubMed ID: 23226513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 and IL-7 differentially induce CD4-CD8- alpha beta TCR+NK1.1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8- alpha beta TCR+NK1.1- cells: implications for the regulation of Th1- and Th2-type responses.
    Nishizawa K; Koyasu S
    Int Immunol; 1997 Aug; 9(8):1123-9. PubMed ID: 9263009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma.
    Swanson SJ; Rosenzweig A; Seidman JG; Libby P
    Arterioscler Thromb; 1994 Jul; 14(7):1210-4. PubMed ID: 8018677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor repertoire in neuroblastoma patients.
    Valteau D; Scott V; Carcelain G; Hartmann O; Escudier B; Hercend T; Triebel F
    Cancer Res; 1996 Jan; 56(2):362-9. PubMed ID: 8542593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of restricted T-cell receptor beta-chain variable region (V beta) usage of reactive T-lymphocytes in Hodgkin's disease.
    Meggetto F; al Saati T; Rubin B; Delsol G
    Br J Haematol; 1994 Mar; 86(3):524-32. PubMed ID: 8043434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins.
    Hawes GE; Struyk L; van den Elsen PJ
    J Immunol; 1993 Mar; 150(5):2033-45. PubMed ID: 8436833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.